Significados de fibrinolytic agents en inglés

However, the impact of diabetes on survival in patients treated with fibrinolytic agents is still undefined.

Attempts to improve thrombolytic treatment include the search for better fibrinolytic agents and more effective adjunctive therapies.

The latter might in part be explained by increasing use concomitant antiplatelet therapy, pre-hospital treatment and fibrin-specific fibrinolytic agents.

Conclusions: A history of diabetes is associated with a worse prognosis after myocardial infarction, even in patients treated with fibrinolytic agents.

Methods: We analyzed prevalence and prognostic significance of a history of diabetes in patients enrolled in the GISSI-2 study, all of whom received fibrinolytic agents.

Plasmin is the prototype of a distinct class of "direct-acting" fibrinolytic agents, with biochemical and physiological attributes that are favorable for catheter-delivered thrombolytic therapy.